Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | PYGM | P11217 | 3/20 | 0.34 |
| ▸ | TK2 | O00142 | 3/20 | 0.33 |
| ▸ | TK1 | P04183 | 1/20 | 0.33 |
| ▸ | PYGB | P11216 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28991368 | 0.90 | LMNA (0.36) | LMNAALOX12ADRA1ASMN1; SMN2PYGM | |
| SCHEMBL8744204 | 0.78 | TK1 (0.40) | LMNAADRA1ATK2TK1 | |
| SCHEMBL28639274 | 0.78 | LMNA (0.39) | LMNAALOX12ADRA1ASMN1; SMN2TK2 | |
| SCHEMBL28293098 | 0.78 | LMNA (0.31) | LMNASMN1; SMN2PYGB | |
| SCHEMBL28252054 | 0.77 | SLC28A1 (0.46) | PYGMPYGB | |
| SCHEMBL9216459 | 0.75 | ALDH1A1 (0.35) | LMNAADRA1ATK2TK1 | |
| SCHEMBL9226219 | 0.75 | LMNA (0.39) | LMNAALOX12ADRA1ASMN1; SMN2PYGM | |
| SCHEMBL8987848 | 0.75 | TK1 (0.36) | LMNAADRA1ATK2TK1 | |
| SCHEMBL9229159 | 0.74 | LMNA (0.35) | LMNASMN1; SMN2 | |
| SCHEMBL9227559 | 0.74 | LMNA (0.39) | LMNAALOX12ADRA1ASMN1; SMN2TK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109641931-A | Method for synthesizing ribonucleic acid H-phosphate monomer and oligonucleotide synthesis using the same | 基因设计有限公司 | 2019-04-16 | — | — | CN | disclosed |